[The I-PRESERVE study].
Trimarco
Bruno
B
Dipartimento di Medicina Clinica e Scienze Cardiovascolari ed Immunologiche, Università degli Studi "Federico II", Napoli. trimarco@unina.it
Rosei
Enrico Agabiti
EA
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D006801:Humans; D000077405:Irbesartan; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D013318:Stroke Volume / Q000187:drug effects*; D016019:Survival Analysis; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan